Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Twist Bioscience CEO Emily Leproust sold 5,139 shares of common stock on August 5, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

  • On August 5, 2024, Emily M. Leproust, CEO of Twist Bioscience Corp, sold 5,139 shares of common stock at a price of $39.926 per share.
  • The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • Following the transaction, Leproust directly owns 499,593 shares of Twist Bioscience Corp.
  • Leproust also holds various employee stock options with different exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction to cover tax obligations. It doesn't convey any strong positive or negative sentiment.

Industry Context

This is a routine transaction for covering tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, although it is a routine transaction.

Key Dates

DateDescription
12/19/2022Performance stock options vested and became exercisable.
08/05/2024Date of transaction: Leproust sold 5,139 shares of TWST.
08/07/2024Date of signature for the Form 4 filing.
09/28/2025Expiration date for employee stock options with an exercise price of $5.95.
09/28/2027Expiration date for employee stock options with an exercise price of $8.82.
11/18/2028Expiration date for employee stock options with an exercise price of $26.66.
10/23/2029Expiration date for employee stock options with an exercise price of $23.33.
08/31/2030Expiration date for employee stock options with an exercise price of $67.85.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.